Pharmaceutical Grade Nitrofurantoin Raw Material Nitrofurantoin Powder Antibacterial Nitrofurantoin

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-sung-Nitrofurantoin
• Product Name: Nitrofurantoin
• Name: Nitrofurantoin Powder
• Appearance: Yellow Powder
• Color: Yellow Color
• Grade: Pharm Grade
• Assay: HPLC 99%
• Application: Antibacterial
• Specific: COA
• Test Method: HPLC UV
• CAS: 67-20-9
• Mf: C8h6n4o5
• MW: 238
• Einecs: 200-646-5
• Hc: 29349990
• Melting Point: 268
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Xi′an Shaanxi
• Production Capacity: 5000kg/Month

Product Description

Pharmaceutical Grade Nitrofurantoin Raw Material Nitrofurantoin Powder Antibacterial Nitrofurantoin

Product Description

Product Datails

Product Name	Nitrofurantoin
Appearance	Yellow powder
Assay	99%min
Test	HPLC
Usage	Pharma grade
CAS	67-20-9
MF	C8H6N4O5

Nitrofurantoin, sold under the trade name Macrobid among others, is an antibiotic used to treat bladder infections.It is not
effective for kidney infections. It is taken by mouth. Common side effects include nausea, loss of appetite, diarrhea, and headaches. Rarely numbness, lung problems, or liver problems may occur. It should not be used in people with kidney problems.While it looks like it is generally safe during pregnancy it should not be used near delivery.It works by slowing growth rather than killing bacteria.

Application&Function

Nitrofurantoin has been available for the treatment of urinary tract infections (UTIs) since 1953. Its current uses include the treatment of uncomplicated UTIs and prophylaxis against UTIs in people prone to recurrent UTIs. Increasing bacterial antibiotic resistance to other commonly used agents, such as fluoroquinolones and trimethoprim/sulfamethoxazole, has led to increased interest in using nitrofurantoin.
Several trials comparing nitrofurantoin to other commonly used agents have shown this drug results in similar cure rates for uncomplicated UTIs.The efficacy of nitrofurantoin in treating UTIs combined with a low rate of bacterial resistance to this agent makes it one of the first-line agents for treating uncomplicated UTIs as recommended by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.Nitrofurantoin is not recommended for the treatment ofpyelonephritis,prostatitis and intra-abdominal abscess,because of extremely poor tissue penetration and low blood levels. It is used in the treatment of infections caused by these organisms.

Specification